Reaction
Pulmonary Mycosis reporting signals
As of the last recalculation, Pulmonary Mycosis appears in 780 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is VORICONAZOLE (PRR 55.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Voriconazole | 58 | 55.0 | 55.1 |
| Micafungin Sodium | 16 | 51.4 | 51.5 |
| Itraconazole | 19 | 44.5 | 44.5 |
| Voriconazole Injection | 26 | 33.0 | 33.1 |
| Ganciclovir | 11 | 29.1 | 29.1 |
| Ganciclovir Sodium | 11 | 28.1 | 28.1 |
| Melphalan Hydrochloride | 22 | 24.1 | 24.1 |
| Melphalan | 19 | 22.8 | 22.8 |
| Misoprostol | 8 | 22.1 | 22.2 |
| Cytarabine | 43 | 20.2 | 20.2 |
| Posaconazole | 12 | 20.0 | 20.0 |
| Sirolimus | 9 | 18.0 | 18.0 |
| Fludarabine Phosphate | 25 | 17.5 | 17.5 |
| Posaconazole Delayed-Release | 7 | 17.2 | 17.2 |
| Bendamustine Hydrochloride | 7 | 15.7 | 15.7 |
| Etoposide | 39 | 14.8 | 14.9 |
| Bendamustine Hcl | 8 | 13.9 | 13.9 |
| Azacitidine | 15 | 13.7 | 13.7 |
| Bleomycin Sulfate | 5 | 13.0 | 13.0 |